Epic Medical Research Joins hyperCORE International's Global Network, Expanding Clinical Trial Capabilities
Epic Medical Research's inclusion in hyperCORE International's global partner site network signifies a strategic expansion in clinical research capabilities, enhancing the delivery of innovative and efficient clinical trial solutions across a wide range of therapeutic areas.
Epic Medical Research has become the latest member of hyperCORE International's global partner site network, a move that significantly enhances the clinical research organization's capabilities and reach. Based in Dallas, Texas, Epic operates across 12 state-of-the-art locations in four states, offering comprehensive clinical trial services across various therapeutic areas, including metabolic disorders, fatty liver disease, and infectious diseases, among others.
The partnership with hyperCORE International, a network of leading clinical research site organizations, provides Epic Medical Research with access to greater resources and shared expertise. hyperCORE International boasts over 80 active trial sites across five countries and two continents, having completed more than 7,000 studies with over 140,000 participants. This collaboration is expected to streamline operations and accelerate results in clinical research.
Dr. Haresh Boghara, President & Principal Investigator at Epic Medical Research, expressed enthusiasm about the partnership, highlighting the shared commitment to advancing clinical research and improving patient outcomes. Similarly, Nicholas Focil, President of hyperCORE International, welcomed Epic's impressive therapeutic breadth and operational scale to the network, emphasizing the alignment with hyperCORE's mission to elevate trial performance.
Founded in 2019, hyperCORE International integrates harmonized operational frameworks among its partner members to optimize efficiency, standardization, and excellence in clinical research. The addition of Epic Medical Research to its network underscores hyperCORE's commitment to advancing clinical research through safe, ethical, and timely studies, supported by top-tier awards for performance, quality, and innovation.